Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Insights and Forecast to 2027
Table of Contents1 Study Coverage
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type
1.4.2 Single Dose Vial
1.4.3 Pre-filled Syringe
1.3 Market by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (?65)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Regions by Sales
2.4.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Regions by Sales (2022-2027)
2.5 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Regions by Revenue
2.5.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
3.1.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by 23-Valent Pneumococcal Polysaccharide Vaccine Sales in 2020
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers
3.2.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2020
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2027)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type
4.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2016-2021)
4.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Sales by Application (2016-2021)
5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Sales by Application (2022-2027)
5.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2027)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application
5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Revenue by Application (2016-2021)
5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Revenue by Application (2022-2027)
5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2027)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application
5.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2016-2021)
5.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2022-2027)
6 North America
6.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
6.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2027)
6.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2027)
6.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
6.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2027)
6.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2027)
6.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
6.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2027)
6.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2027)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2027)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
7.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2027)
7.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2027)
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
7.3.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2027)
7.3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
8.1.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2018-2027)
8.1.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2018-2027)
8.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
8.2.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2018-2027)
8.2.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2018-2027)
8.3 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.3.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2018-2027)
8.3.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
9.1.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2019-2027)
9.1.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2019-2027)
9.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
9.2.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2019-2027)
9.2.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2019-2027)
9.3 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
9.3.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2019-2027)
9.3.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
6.1.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2027)
6.1.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2027)
6.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
6.2.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2027)
6.2.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2027)
6.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
6.3.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2027)
6.3.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 MSD
11.1.1 MSD Corporation Information
11.1.2 MSD Overview
11.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Description
11.1.5 MSD Related Developments
11.2 Sanofipasteur
11.2.1 Sanofipasteur Corporation Information
11.2.2 Sanofipasteur Overview
11.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Description
11.2.5 Sanofipasteur Related Developments
11.3 CDIBP
11.3.1 CDIBP Corporation Information
11.3.2 CDIBP Overview
11.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Description
11.3.5 CDIBP Related Developments
11.1 MSD
11.1.1 MSD Corporation Information
11.1.2 MSD Overview
11.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Description
11.1.5 MSD Related Developments
12 Value Chain and Sales Channels Analysis
12.1 23-Valent Pneumococcal Polysaccharide Vaccine Value Chain Analysis
12.2 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 23-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
12.4 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Marketing
12.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channels
12.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
12.5 23-Valent Pneumococcal Polysaccharide Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
13.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
13.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
13.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
14 Key Findings in The Global 23-Valent Pneumococcal Polysaccharide Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesTable 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Single Dose Vial
Table 3. Major Manufacturers of Pre-filled Syringe
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2022-2027)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2022-2027)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2016-2021) & (K Dose)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturers 2016-2021 (USD/Dose)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2020)
Table 21. 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 23. Date of Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2016-2021)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2022-2027)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2016-2021)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2022-2027)
Table 33. 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2016-2021) & (USD/Dose)
Table 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2022-2027) & (USD/Dose)
Table 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2016-2021)
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2022-2027)
Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2016-2021)
Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2022-2027)
Table 43. 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2016-2021) & (USD/Dose)
Table 44. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2022-2027) & (USD/Dose)
Table 45. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 46. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 47. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 50. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 51. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 54. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2022-2027) & (K Dose)
Table 55. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 58. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 59. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 62. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 63. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 66. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2022-2027) & (K Dose)
Table 67. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 70. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 71. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 74. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 75. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 78. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2022-2027) & (K Dose)
Table 79. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 82. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 83. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 86. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 87. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 90. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2022-2027) & (K Dose)
Table 91. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 94. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 95. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 98. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 99. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 102. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2022-2027) & (K Dose)
Table 103. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 105. MSD Corporation Information
Table 106. MSD Description and Major Businesses
Table 107. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 108. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 109. MSD Recent Developments
Table 110. Sanofipasteur Corporation Information
Table 111. Sanofipasteur Description and Major Businesses
Table 112. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 114. Sanofipasteur Recent Developments
Table 115. CDIBP Corporation Information
Table 116. CDIBP Description and Major Businesses
Table 117. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 119. CDIBP Recent Developments
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 123. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 124. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Table 125. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
Table 126. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 127. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of FiguresFigure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type in 2020 & 2027
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020 & 2027
Figure 6. For Children (2-10)
Figure 7. For Person (10-64)
Figure 8. For The Old (?65)
Figure 9. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2027 (K Dose)
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2027 (US$ Million)
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Figure 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2022-2027)
Figure 16. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2016-2027) & (K Dose)
Figure 17. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2016-2027) & (K Dose)
Figure 19. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2016-2027) & (K Dose)
Figure 21. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2016-2027) & (K Dose)
Figure 23. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2016-2027) & (K Dose)
Figure 25. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2020
Figure 28. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2027)
Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2027)
Figure 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2027)
Figure 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2027)
Figure 33. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2027)
Figure 34. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2027)
Figure 35. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2027)
Figure 36. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2027)
Figure 37. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2016-2027)
Figure 38. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2016-2027)
Figure 39. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2016-2027) & (US$ Million)
Figure 40. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2016-2027) & (US$ Million)
Figure 41. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2027)
Figure 42. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2027)
Figure 43. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2027)
Figure 44. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2027)
Figure 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2016-2027)
Figure 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2016-2027)
Figure 47. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2016-2027) & (US$ Million)
Figure 48. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2016-2027) & (US$ Million)
Figure 50. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2016-2027) & (US$ Million)
Figure 51. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific 23-Valent Pne